Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
PR Newswire Association LLC.
Osstem Implant to Strengthen "Growing Together with Customers" Strategy in 2026
10 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
25 Mar 2026
GlobeNewswire
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
25 Mar 2026
PR Newswire Association LLC.
South Korean Aesthetic Sector Sees Growing International Demand for Liquid PCL Technology and "Skin Quality" Treatments
24 Mar 2026
GlobeNewswire
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
23 Mar 2026
GlobeNewswire
MEDVi Quad Prescription Access Updated as Telehealth ED Treatment Demand Rises in 2026
23 Mar 2026
PR Newswire Association LLC.
Korea University Study Identifies Liver-Metabolic Disease as a Key Risk Factor for Heart Failure in Older Adults with Atrial Fibrillation
23 Mar 2026
PR Newswire Association LLC.
Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation
16 Mar 2026
PR Newswire Association LLC.
Dongguk University Researchers Develop Breakthrough Material for Powering Next-Generation Smart Devices
13 Mar 2026
GlobeNewswire
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13 Mar 2026
PR Newswire Association LLC.
Jeonbuk National University Researchers Develop DDINet For Accurate and Scalable Drug-Drug Interaction Prediction
11 Mar 2026
PR Newswire Association LLC.
K-pop Singer and Actress Kim Sejeong Named Global Brand Ambassador for 'REJURAN' and 'REJURAN COSMETICS'
10 Mar 2026
PR Newswire Association LLC.
Jeonbuk National University Researchers Develop an AI Model For Personalized Blood Glucose Monitoring
09 Mar 2026
GlobeNewswire
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
24 Feb 2026
PR Newswire Association LLC.
Won BioGen Accelerates Global Market Expansion with Advanced Moist Wound Care Technology
24 Feb 2026
PR Newswire Association LLC.
Jeonbuk National University Researchers Explore Metal Oxide Electrodes as a New Frontier in Electrochemical Microplastic Detection
19 Feb 2026
PR Newswire Association LLC.
Hanyang University ERICA Researchers Identify Key Mechanism Driving Progression of Fatty Liver Disease to Cancer
16 Feb 2026
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
29 Mar 2026
GlobeNewswire
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
27 Mar 2026
GlobeNewswire
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
20 Mar 2026
GlobeNewswire
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
06 Mar 2026
GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
27 Feb 2026
GlobeNewswire
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
27 Feb 2026
Latest News All News
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum